News Releases Home Synthetic Biology The History of Synthetic Biology Living Medicines Designing Synthetic Biotic™ Medicines Pipeline + Programs For Patients Our People Leadership Board of Directors Founders and Advisors Join Us Investors + Media Company Overview News & Events News Releases Event Calendar Presentations & Publications Stock Information Corporate Governance Financials Investor Resources Items Per Page 102550 Year None201920182017201620152014 March 12, 2019 Synlogic Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update March 6, 2019 Synlogic Announces Achievement of Milestone in Collaboration to Develop Synthetic Biotic™ Medicines to Treat Inflammatory Bowel Disease March 5, 2019 Synlogic Announces Fourth Quarter and Full Year 2018 Conference Call and Webcast February 28, 2019 Synlogic to Present at Investor Conferences in March February 20, 2019 Synlogic to Webcast Presentation at the SVB Leerink 8th Annual Global Healthcare Conference February 12, 2019 Synlogic Appoints Patricia N. Hurter, Ph.D. to Board of Directors January 16, 2019 Science Translational Medicine Publishes First-in-Human Clinical Data and Supporting Preclinical Data for SYNB1020, Synlogic’s Synthetic Biotic™ Medicine in Development as a Potential Treatment for Hyperammonemia January 3, 2019 Synlogic Progresses Clinical and Preclinical Pipeline and Outlines 2019 Catalysts December 12, 2018 Synlogic Expands Capabilities in Manufacturing with the Appointment of Head of Technical Operations and Establishment of In-house Production of Clinical Trial Material for its Synthetic BioticTM Medicines November 20, 2018 Synlogic to Webcast Presentation at the 30th Annual Piper Jaffray Healthcare Conference Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Next page next › Last page last » Displaying 11 - 20 of 85 Email Alerts Contact IR RSS Feeds Print Page Email Page
Items Per Page 102550 Year None201920182017201620152014 March 12, 2019 Synlogic Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update March 6, 2019 Synlogic Announces Achievement of Milestone in Collaboration to Develop Synthetic Biotic™ Medicines to Treat Inflammatory Bowel Disease March 5, 2019 Synlogic Announces Fourth Quarter and Full Year 2018 Conference Call and Webcast February 28, 2019 Synlogic to Present at Investor Conferences in March February 20, 2019 Synlogic to Webcast Presentation at the SVB Leerink 8th Annual Global Healthcare Conference February 12, 2019 Synlogic Appoints Patricia N. Hurter, Ph.D. to Board of Directors January 16, 2019 Science Translational Medicine Publishes First-in-Human Clinical Data and Supporting Preclinical Data for SYNB1020, Synlogic’s Synthetic Biotic™ Medicine in Development as a Potential Treatment for Hyperammonemia January 3, 2019 Synlogic Progresses Clinical and Preclinical Pipeline and Outlines 2019 Catalysts December 12, 2018 Synlogic Expands Capabilities in Manufacturing with the Appointment of Head of Technical Operations and Establishment of In-house Production of Clinical Trial Material for its Synthetic BioticTM Medicines November 20, 2018 Synlogic to Webcast Presentation at the 30th Annual Piper Jaffray Healthcare Conference Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Next page next › Last page last » Displaying 11 - 20 of 85
March 12, 2019 Synlogic Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
March 6, 2019 Synlogic Announces Achievement of Milestone in Collaboration to Develop Synthetic Biotic™ Medicines to Treat Inflammatory Bowel Disease
February 20, 2019 Synlogic to Webcast Presentation at the SVB Leerink 8th Annual Global Healthcare Conference
January 16, 2019 Science Translational Medicine Publishes First-in-Human Clinical Data and Supporting Preclinical Data for SYNB1020, Synlogic’s Synthetic Biotic™ Medicine in Development as a Potential Treatment for Hyperammonemia
December 12, 2018 Synlogic Expands Capabilities in Manufacturing with the Appointment of Head of Technical Operations and Establishment of In-house Production of Clinical Trial Material for its Synthetic BioticTM Medicines
November 20, 2018 Synlogic to Webcast Presentation at the 30th Annual Piper Jaffray Healthcare Conference